BIOEPCIN Trademark

Trademark Overview

On Tuesday, March 28, 2023, a trademark application was filed for BIOEPCIN with the United States Patent and Trademark Office. The USPTO has given the BIOEPCIN trademark a serial number of 97860018. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, July 28, 2025. This trademark is owned by Biocon Limited. The BIOEPCIN trademark is filed in the Medical Instrument Products category with the following description:

Medical fluid injectors
bioepcin

General Information

Serial Number97860018
Word MarkBIOEPCIN
Filing DateTuesday, March 28, 2023
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, July 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2024

Trademark Statements

Goods and ServicesMedical fluid injectors

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, April 19, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiocon Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressKarnataka 560100
IN
Party NameBiocon Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressKarnataka 560100
IN

Trademark Events

Event DateEvent Description
Friday, March 31, 2023NEW APPLICATION ENTERED
Wednesday, April 19, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 20, 2023ASSIGNED TO EXAMINER
Friday, September 29, 2023NON-FINAL ACTION WRITTEN
Friday, September 29, 2023NON-FINAL ACTION E-MAILED
Friday, September 29, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 29, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 29, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 29, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 6, 2023EXAMINERS AMENDMENT E-MAILED
Monday, November 6, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, November 6, 2023EXAMINERS AMENDMENT E-MAILED
Monday, November 6, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 6, 2023EXAMINER'S AMENDMENT ENTERED
Monday, November 6, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, November 6, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 6, 2023EXAMINER'S AMENDMENT ENTERED
Monday, December 4, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 3, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 5, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 3, 2024SOU EXTENSION 1 FILED
Tuesday, September 3, 2024SOU EXTENSION 1 GRANTED
Tuesday, January 21, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, January 21, 2025SOU EXTENSION 2 FILED
Tuesday, January 21, 2025SOU EXTENSION 2 GRANTED
Monday, July 28, 2025SOU TEAS EXTENSION RECEIVED
Monday, July 28, 2025SOU EXTENSION 3 FILED
Monday, July 28, 2025SOU EXTENSION 3 GRANTED
Tuesday, July 29, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

bioepcin injectors fluid medical